chr22-38143034-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003560.4(PLA2G6):​c.609+71A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 1,433,638 control chromosomes in the GnomAD database, including 148,246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18628 hom., cov: 31)
Exomes 𝑓: 0.44 ( 129618 hom. )

Consequence

PLA2G6
NM_003560.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.499

Publications

20 publications found
Variant links:
Genes affected
PLA2G6 (HGNC:9039): (phospholipase A2 group VI) The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010]
PLA2G6 Gene-Disease associations (from GenCC):
  • neurodegeneration with brain iron accumulation 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • neurodegeneration with brain iron accumulation 2B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • PLA2G6-associated neurodegeneration
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive Parkinson disease 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 22-38143034-T-C is Benign according to our data. Variant chr22-38143034-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLA2G6NM_003560.4 linkc.609+71A>G intron_variant Intron 4 of 16 ENST00000332509.8 NP_003551.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLA2G6ENST00000332509.8 linkc.609+71A>G intron_variant Intron 4 of 16 1 NM_003560.4 ENSP00000333142.3

Frequencies

GnomAD3 genomes
AF:
0.485
AC:
73621
AN:
151794
Hom.:
18612
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.607
Gnomad AMI
AF:
0.540
Gnomad AMR
AF:
0.490
Gnomad ASJ
AF:
0.467
Gnomad EAS
AF:
0.290
Gnomad SAS
AF:
0.565
Gnomad FIN
AF:
0.388
Gnomad MID
AF:
0.585
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.475
GnomAD4 exome
AF:
0.445
AC:
570260
AN:
1281726
Hom.:
129618
Cov.:
18
AF XY:
0.449
AC XY:
290189
AN XY:
646784
show subpopulations
African (AFR)
AF:
0.617
AC:
18510
AN:
29988
American (AMR)
AF:
0.480
AC:
21357
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
11618
AN:
25076
East Asian (EAS)
AF:
0.272
AC:
10574
AN:
38828
South Asian (SAS)
AF:
0.555
AC:
45809
AN:
82476
European-Finnish (FIN)
AF:
0.396
AC:
20513
AN:
51844
Middle Eastern (MID)
AF:
0.538
AC:
2943
AN:
5474
European-Non Finnish (NFE)
AF:
0.436
AC:
414160
AN:
949048
Other (OTH)
AF:
0.455
AC:
24776
AN:
54492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
17635
35269
52904
70538
88173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11816
23632
35448
47264
59080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.485
AC:
73692
AN:
151912
Hom.:
18628
Cov.:
31
AF XY:
0.484
AC XY:
35957
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.607
AC:
25170
AN:
41456
American (AMR)
AF:
0.490
AC:
7469
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.467
AC:
1619
AN:
3470
East Asian (EAS)
AF:
0.290
AC:
1491
AN:
5148
South Asian (SAS)
AF:
0.564
AC:
2714
AN:
4808
European-Finnish (FIN)
AF:
0.388
AC:
4090
AN:
10544
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29470
AN:
67934
Other (OTH)
AF:
0.478
AC:
1005
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1882
3764
5647
7529
9411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.460
Hom.:
2763
Bravo
AF:
0.494
Asia WGS
AF:
0.480
AC:
1673
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 38% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 35. Only high quality variants are reported.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.5
DANN
Benign
0.79
PhyloP100
-0.50
PromoterAI
-0.00040
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4375; hg19: chr22-38539041; COSMIC: COSV59268338; COSMIC: COSV59268338; API